References
- Daniels G. Human blood groups. Oxford: Blackwell Science, 1995:452-65.
- Levine P, Robinson EA, Layrisse M, Arends T, Dominques SR. The Diego blood factor. Nature 1956;277:40-1.
- Thompson PR, Childers DM, Hatcher DE. Anti-Dib—first and second examples. Vox Sang 1967;13:314-8.
- Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine. 9th ed. Oxford: Blackwell Science, 1993: 268-9.
- Lin-Chu M, Broadberry RE, Chang FC, Ting F. Haemolytic disease of the newborn (HDN) due to maternal anti-Dib in a Chinese infant. In: Book of Abstracts of the Second Regional Congress, Western Pacific Region of International Society of Blood Transfusion, Hong Kong; 1991:32.
- [6]Zafar M, Reid ME. Review: the Diego blood group system. Immunohematology 1993;9:35-40. 7.Mak KH, Cheng S, Yuen C, Chua E, Lin CK, Leong S. Survey of blood group distribution among Chinese blood donors in Hong Kong—an update. Vox Sang 1994;67:82-94.
- Walker RH, ed. Techical manual. 11th ed. Bethesda, MD: American Association of Blood Banks, 1993.
- Marsh WL. Scoring of hemagglutination reactions. Transfusion 1972;12:352-3.
- Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449-52.
- Schanfield MS, Schoeppner SL, Stevens JO. New approaches to detecting clinically significant antibodies in the laboratory. In: Sandler SG, Nusbacher J, Schanfield MS, eds. Immunobiology of the erythrocyte. New York: Alan R. Liss, 1980:305-23.
- Habash J, Devenish A, Macdonald S, Garner S, Contreras M. A further example of anti-Dib not causing haemolytic disease of the newborn. Vox Sang 1991;61:77.
- Feller CW, Shenker L, Scott EP, Marsh WL. An anti-Diego (Dib) antibody occurring during pregnancy. Transfusion 1970;10: 279-80.
- Uchikawa M, Shibata Y, Tohyama H, Mori H, Aisaka K, Nakagawa M. A case of haemolytic disease of the newborn due to anti-Dib antibodies. Vox Sang 1982;42:91-2.
- Issitt PD. Applied blood group serology. 3rd ed. Miami, FL: Montgomery Scientific Publications, 1985:387.
- Orlina AR, Unger PJ. Hemolytic disease of the newborn due to anti-Dib. Am J Clin Pathol 1979;71:713-4.
- Nance SJ, Nelson JM, Horenstein J, Arndt PA, Platt LD, Garratty G. Monocyte monolayer assay: an efficient noninvasive technique for predicting the severity of hemolytic disease of the newborn. Am J Clin Pathol 1989;92:89-92.
- Zupanska B, Brojer E, Richards Y, Lenkiewicz B, Seyfried H, Howell P. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn. Vox Sang 1989;56:247-53.
- Schanfield MS, Stevens JO, Bauman D. The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay. Transfusion 1981;21:571-6.
- Branch DR, Gallagher MT. Correlation of in vivo alloantibody significance or insignificance with an in vivo monocytemacrophage phagocytosis assay. Br J Haematol 1986;62:783-5.
- Lucas GF, Hadley AG, Nance SJ, Garratty G. Predicting hemolytic disease of the newborn: a comparison of the monocyte monolayer assay and the chemiluminescence test. Transfusion 1993;33:484-7.
- Sacks DA, Nance SJ, Garratty G, Petrucha RA, Horenstein J, Fotheringham N. Monocyte monolayer assay as a prediction of severity of hemolytic disease of the fetus and newborn. Am J Perinatol 1993;10:428-31.